EUVIMEDEUVIMED entdecken
Crossref

Design, Hemisynthesis, Characterization, Molecular Docking, and Dynamics Evaluation of Novel Totarol‐1,2,3‐Triazole Derivatives as Leishmaniasis and Toxoplasmosis Agents

Ayoub Boualli, Yassine Laamari, Abdoullah Bimoussa iD, Syeda Abida Ejaz, Hafiz Muhammad Attaullah, Abdelkhalek Riahi, Anthony Robert, Jean-Claude Daran, Ibrahim S Al Nasr, Waleed S Koko, Tariq A Khan, Bernhard Biersack und 2 weitere

Chemical Biology & Drug Design · 2025-02 · 105 (2)

DOI: 10.1111/cbdd.70042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 13.02.2025. Verfasst von Ayoub Boualli und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Chemistry, unit of Organic Synthesis and Molecular Physico-Chemistry, Department of Chemistry, Faculty of Sciences Semlalia, …. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Drug Design, Leishmania major, Molecular Docking Simulation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tropical parasitic diseases like leishmaniasis pose significant public health challenges, impacting millions of individuals globally. Current drug treatments for these diseases have notable drawbacks and side effects, underscoring the pressing need for new medications with improved selectivity and reduced toxicity. Through structural modifications of both natural and synthetic compounds using click chemistry, researchers have been able to produce derivatives showing promising activity against these parasites. In this study, 21 novel 1,2,3‐triazole analogues of totarol were synthesized using O ‐propargylated totarol derivatives and substituted arylazide. These compounds were characterized through various analytical techniques, including 1 H NMR, 13 C NMR, and HRMS. An x‐ray crystallographic study of compounds 4 and 6 was carried out to fully establish the structure of the newly prepared totarol derivatives. All synthesized compounds were then screened in vitro for their antileishmanial activities against Leishmania major promastigotes, amastigotes, and Toxoplasma gondii tachyzoites Out of the tested analogues, six compounds ( 7c, 8b–e , and 9 g ) displayed antileishmanial activity against L. major amastigotes with IC 50 17.3, 14.2, 13.1 18.2 13.2 and 17.3 μg mL −1 respectively, while only 8e gave antileishmanial activity against both promastigotes and amastigotes with IC 50 11.7 and 13.2 μg mL −1 respectively. Additionally, the presence of a nitro group was correlated with enhanced antileishmanial activity. Moreover, a molecular docking study was conducted, focusing on 8e , the most active antileishmanial compound, to elucidate its putative binding pattern at the active site of the selected leishmanial trypanothione reductase target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiprotozoal AgentsDrug DesignLeishmania majorMolecular Docking SimulationToxoplasmaTriazolesAnimalsHumansCrystallography, X-RayLeishmaniasisMolecular Dynamics SimulationNADH, NADPH OxidoreductasesStructure-Activity RelationshipToxoplasmosisAbietanes

Stichwörter der Autor:innen

1,2,3‐triazolehemisynthesisin vitroleishmaniasismolecular dockingtotarol

Substanzen

Antiprotozoal AgentsNADH, NADPH OxidoreductasesTriazolestrypanothione reductasetotarolAbietanes

Autor:innen und Institutionen

  • Laboratory of Molecular Chemistry, unit of Organic Synthesis and Molecular Physico-Chemistry, Department of Chemistry, Faculty of Sciences Semlalia, Université Cadi Ayyad, Marrakech, Morocco.
  • Department of Pharmaceutical Chemistry, The Islamia University of Bahawalpur, Bahawalpur, Pakistan.
  • Institut de Chimie Moléculaire de Reims, CNRS UMR 7312 Bât. Euro- pol'Agro - Moulin de la Housse UFR Sciences, Reims, France.
  • Laboratoire de Chimie de Coordination, CNRS UPR8241, 205 route de Narbonne, Toulouse, France.
  • Department of Biology, College of Science, Qassim University, Buraydah, Qassim, Saudi Arabia.
  • Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah, Qassim, Saudi Arabia.

ORCID-Profile: Abdoullah Bimoussa

Zitieren

APA

Boualli, A., Laamari, Y., Bimoussa, A., Ejaz, S. A., Attaullah, H. M., Riahi, A., Robert, A., Daran, J. C., Al Nasr, I. S., Koko, W. S., Khan, T. A., Biersack, B., Auhmani, A., & Itto, M. Y. A. (2025). Design, Hemisynthesis, Characterization, Molecular Docking, and Dynamics Evaluation of Novel Totarol‐1,2,3‐Triazole Derivatives as Leishmaniasis and Toxoplasmosis Agents. Chemical Biology & Drug Design, 105(2). https://doi.org/10.1111/cbdd.70042

Vancouver

Boualli A, Laamari Y, Bimoussa A, Ejaz SA, Attaullah HM, Riahi A, et al. Design, Hemisynthesis, Characterization, Molecular Docking, and Dynamics Evaluation of Novel Totarol‐1,2,3‐Triazole Derivatives as Leishmaniasis and Toxoplasmosis Agents. Chemical Biology & Drug Design. 2025;105(2). doi:10.1111/cbdd.70042

BibTeX
@article{Boualli2025,
  author = {Boualli, Ayoub and Laamari, Yassine and Bimoussa, Abdoullah and Ejaz, Syeda Abida and Attaullah, Hafiz Muhammad and Riahi, Abdelkhalek and Robert, Anthony and Daran, Jean-Claude and Al Nasr, Ibrahim S and Koko, Waleed S and Khan, Tariq A and Biersack, Bernhard and Auhmani, Aziz and Itto, My Youssef Ait},
  title = {Design, Hemisynthesis, Characterization, Molecular Docking, and Dynamics Evaluation of Novel Totarol‐1,2,3‐Triazole Derivatives as Leishmaniasis and Toxoplasmosis Agents},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  volume = {105},
  number = {2},
  doi = {10.1111/cbdd.70042}
}
Kostenlos starten →